Guanethidine monosulfate; hydrochlorothiazide - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for guanethidine monosulfate; hydrochlorothiazide and what is the scope of patent protection?
Guanethidine monosulfate; hydrochlorothiazide
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for guanethidine monosulfate; hydrochlorothiazide
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | guanethidine monosulfate; hydrochlorothiazide at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for guanethidine monosulfate; hydrochlorothiazide
US Patents and Regulatory Information for guanethidine monosulfate; hydrochlorothiazide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | ESIMIL | guanethidine monosulfate; hydrochlorothiazide | TABLET;ORAL | 013553-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |